The pharma company has confirmed reports following patient testimonials and warnings online.
Reverse mergers promise fast access to public markets – but DeeDee DeMan warns founders that leadership and governance readiness often lag behind.
Italian nonprofit Fondazione Telethon and US nonprofit Orphan Therapeutics Accelerator are collaborating to bring curative ...
The firm has closed an oversubscribed Series B, fueling two bold TCR-bispecific programs targeting cancer and autoimmune ...
AbbVie is paying up front and betting on a Japanese biotech's gut-restricted molecule to tackle inflammatory bowel disease ...
Alethio Therapeutics has closed an oversubscribed $90 million Series A, providing the capital to advance to clinical stage.
Boehringer Ingelheim and Microsoft are partnering to build AI-driven digital patient twins that simulate disease progression ...
Rhythm Pharmaceuticals has amended its exclusive license agreement with LG Chem for bivamelagon, an oral small-molecule ...
GSK leader shares tips on how to always keep mature brand speaker programs relevant, credible and compliant over time.
Some have called this announcement a "yellow light" or "backdoor" approval of these gray-market peptides. However, the HHS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results